HEPARAN SULFATE-DEPENDENT AND LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN-DEPENDENT CATABOLIC PATHWAYS FOR LIPOPROTEIN-LIPASE IN MOUSEEMBRYONIC FIBROBLASTS
E. Sehayek et al., HEPARAN SULFATE-DEPENDENT AND LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN-DEPENDENT CATABOLIC PATHWAYS FOR LIPOPROTEIN-LIPASE IN MOUSEEMBRYONIC FIBROBLASTS, Israel journal of medical sciences, 32(6), 1996, pp. 449-454
Heparan sulfate and low density lipoprotein receptor related protein (
LRP) have been shown to participate in the uptake and degradation of t
he enzyme lipoprotein lipase (LPL). Yet, the contribution of each of t
hese pathways to LPL metabolism and their possible dependence is unkno
wn. In the present study we examined the metabolism of I-125-labeled L
PL in untreated and heparinase-treated primary wild-type mouse embryon
ic fibroblasts (MEF) and in mouse fibroblasts that express single LRP
allele (PEA-10) or are lacking the LRP (PEA-13). The degradation of LP
L in PEA-13 cells was 30% lower than in MEF and PEA-10 cells. Heparina
se treatment decreased the LPL degradation by 58%, 79% and 92%, wherea
s heparin reduced such degradation by 87%, 90% and 94% in MEF, PEA-10
and PEA-13 cultures, respectively. Assuming that a) heparinase treatme
nt abolished the heparan-sulfate pathway, and that b) the degradation
remaining in heparin-treated cultures represents nonspecific values, i
t appears that heparan sulfate contributes about 61%, 83% and 95% of t
otal LPL degradation, whereas the LRP pathway contributes 39%, 17% and
less than 5% of LPL degradation in MEF, PEA-10 and PEA-13 cells, resp
ectively. In addition, the data indicate that LPL interaction with hep
aran sulfate and the LRP pathways is independent of each other. The st
udy shows that these cells possess both a heparan sulfate-dependent pa
thway and an LRP-dependent pathway for LPL metabolism and that the two
pathways are independent of each other.